Ufp Technologies (UFPT) Current Deferred Revenue (2017 - 2026)
Ufp Technologies' (UFPT) quarterly Current Deferred Revenue came in at $4.8 million in Q2 2026, up 4.19% on a YoY basis from $4.6 million in Q2 2025, and up 3.78% quarter-over-quarter from $4.6 million in Q1 2026.
Analysis
Ufp Technologies (UFPT) Current Deferred Revenue (2017 - 2026) Analysis & Trends
Ufp Technologies (UFPT) has reported Current Deferred Revenue for 10 consecutive years, with $4.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Current Deferred Revenue rose 4.19% year-over-year to $4.8 million; the trailing twelve-month figure through Jun 2026 stood at $4.8 million (up 4.19% YoY), and the FY2025 full-year result was $4.2 million, down 9.15% from the prior year.
- Current Deferred Revenue rose to $4.8 million in Q2 2026 per UFPT's latest filing, from $4.6 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $6.6 million in Q4 2023 and bottomed at $3.6 million in Q1 2023.
- Historically, Current Deferred Revenue has averaged $4.7 million across 5 years, with a median of $4.6 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Current Deferred Revenue jumped 157.93% in 2022, then slipped 29.46% in 2024.
- Over 5 years, Current Deferred Revenue stood at $4.7 million in 2022, then surged by 41.4% to $6.6 million in 2023, then decreased by 29.46% to $4.7 million in 2024, then retreated by 9.15% to $4.2 million in 2025, then advanced by 13.25% to $4.8 million in 2026.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $4.8 million, $4.6 million, and $4.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Ufp Technologies | 2.15 Bn | 2.14 Bn | 50.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.80 Mn |
| Mar 31, 2026 | 4.63 Mn |
| Dec 31, 2025 | 4.24 Mn |
| Sep 30, 2025 | 4.83 Mn |
| Jun 30, 2025 | 4.61 Mn |
| Mar 31, 2025 | 4.79 Mn |
| Dec 31, 2024 | 4.67 Mn |
| Sep 30, 2024 | 5.80 Mn |
| Jun 30, 2024 | 4.55 Mn |
| Mar 31, 2024 | 4.53 Mn |
| Dec 31, 2023 | 6.62 Mn |
| Sep 30, 2023 | 3.81 Mn |
| Jun 30, 2023 | 4.27 Mn |
| Mar 31, 2023 | 3.58 Mn |
| Dec 31, 2022 | 4.68 Mn |
| Sep 30, 2022 | 4.17 Mn |
| Jun 30, 2022 | 5.61 Mn |
| Mar 31, 2022 | 5.04 Mn |
| Dec 31, 2021 | 4.25 Mn |
| Sep 30, 2021 | 2.81 Mn |